BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/6/2014 11:02:00 AM | Browse: 1108 | Download: 877
Publication Name World Journal of Gastroenterology
Manuscript ID 8243
Country Italy
Received
2013-12-22 13:14
Peer-Review Started
2013-12-23 09:58
To Make the First Decision
2014-01-15 19:31
Return for Revision
2014-03-26 14:07
Revised
Second Decision
2014-04-16 11:32
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-16 12:03
Articles in Press
2014-05-23 10:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-04-24 22:23
Typeset the Manuscript
2014-07-12 14:49
Publish the Manuscript Online
2014-07-26 13:36
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Field of Vision
Article Title Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?
Manuscript Source Invited Manuscript
All Author List Antonella Scalera and Giovanni Tarantino
Funding Agency and Grant Number
Corresponding Author Giovanni Tarantino, MD, Department of Clinical Medicine and Surgery, Federico II University Medical School of Naples, Via Sergio Pansini 5, 80131 Naples, Italy. tarantin@unina.it
Key Words Hepatocarcinoma; Non-alcoholic fatty liver disease; Insulin growth factor; Peroxisome proliferator-activated receptor γ; Adipokines
Core Tip Obesity, metabolic syndrome and type 2 diabetes mellitus are strictly related and are key pathogenetic factors in non-alcoholic fatty liver disease, one of the most frequent liver diseases worldwide. It is necessary to stress that one of the most important consequences of the “metabolic epidemics” is the probable rise in the incidence of cancers, particularly hepatocarcinoma. Thus, to improve survival, efforts to achieve a “healthier diet” should be promoted by physicians and politicians, even though no changes in genes have been observed in the postprandial state induced after the acute effect of specific diets in patients exhibiting non-alcoholic fatty liver disease and insulin resistance.
Publish Date 2014-07-26 13:36
Citation Scalera A, Tarantino G. Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? World J Gastroenterol 2014; 20(28): 9217-9228
URL http://www.wjgnet.com/1007-9327/full/v20/i28/9217.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i28.9217
Full Article (PDF) WJG-20-9217.pdf
Full Article (Word) WJG-20-9217.doc
Manuscript File 8243-Review.doc
Answering Reviewers 8243-Answering reviewers.pdf
Copyright License Agreement 8243-Copyright assignment.pdf
Peer-review Report 8243-Peer review.pdf
Scientific Editor Work List 8243-Scientific editor work list.doc